SCHEMBL1301699

SCHEMBL1301699

COC(=O)c1ccccc1Nc1ccc(-c2ccc(Br)cc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.69
ALOX15 P16050 1/20 0.69
SLC6A3 Q01959 1/20 0.64
KDM4E B2RXH2 6/20 0.56
ALDH1A1 P00352 4/20 0.56
RAB9A P51151 2/20 0.56
HPGD P15428 1/20 0.56
SIRT2 Q8IXJ6 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.53
POLB P06746 2/20 0.53
ATM Q13315 1/20 0.53
KMT2A Q03164 3/20 0.49
PSMD14 O00487 1/20 0.49
MMP2 P08253 1/20 0.49
DNMT1 P26358 1/20 0.49
RECQL P46063 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
AURKA O14965 1/20 0.48
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17617073 0.95 MAPT (0.76) MAPTALOX15SLC6A3KDM4EALDH1A1
SCHEMBL12109319 0.92 MAPT (0.81) MAPTALOX15SLC6A3KDM4EHPGD
SCHEMBL28649151 0.89 MAPT (0.81) MAPTALOX15SLC6A3KDM4EALDH1A1
SCHEMBL13224505 0.87 MAPT (0.89) MAPTALOX15KDM4EALDH1A1HPGD
SCHEMBL12109338 0.85 MAPT (0.69) MAPTALOX15SLC6A3KDM4EALDH1A1
SCHEMBL31914 0.82 MAPT (1.00) MAPTALOX15KDM4EALDH1A1HPGD
SCHEMBL28658698 0.81 MAPT (0.78) MAPTALOX15KDM4EALDH1A1RAB9A
SCHEMBL13832955 0.80 MAPT (0.76) MAPTALOX15SLC6A3KDM4EALDH1A1
SCHEMBL22452889 0.80 MAPT (0.76) MAPTALOX15KDM4EALDH1A1HPGD
SCHEMBL22853361 0.80 MAPT (0.76) MAPTALOX15SLC6A3KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034485-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2015-05-19 US disclosed
US-9034485-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2015-05-19 US disclosed
US-9034485-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2015-05-19 US disclosed
US-20110266533-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2011-11-03 US disclosed
US-20110266533-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2011-11-03 US disclosed
US-20110266533-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2011-11-03 US disclosed
WO-2010083871-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2010-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110266533-A1 COMPOUNDS FOR ELECTRONIC DEVICES SLCO2A1, SLC40A1, TOE1 MAPT 1198/4885ALOX15 874/4885SLC6A3 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.